Neuroprotective effects, with a decreased risk of Alzheimers disease, dementia, and seizures
Factor in consultation fees, required lab work, and shipping charges
Their smaller molecular structure also facilitates better tissue penetration and lower production costs, which could enhance accessibility to these novel medications
- Can be incorporated into daily wellness routines
PMID: 16529340 DOI: 10.1331/154434506775268698 Tushuizen ME et al (2006): Incretin mimetics as a novel therapeutic option for hepatic steatosis
Unlike MC4R-targeted agonists such as setmelanotide, whose efficacy is intrinsically limited by the functional status of the impaired receptor, GLP-1 RAs operate via pathways largely independent of the leptin-melanocortin circuitry